Jeffrey A Toretsky (Jeffrey Toretsky)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 6

Top Topics

Cell Cycle Arrest

Top Venues

Science signaling

Journal of clinical medicine

Science advances

Science (New York, N.Y.)

This page only lists publications with an associated author ORCID identifier.

Publications

Paul A Meyers, Noah Federman, Najat C Daw, Peter M Anderson, Lara E Davis, AeRang Kim, Margaret E Macy, Angela Pietrofeso, Ravin Ratan, Richard F Riedel, Matteo Trucco, James B Breitmeyer, Jeffrey A Toretsky, Joseph A Ludwig
Open-Label, Multicenter, Phase I/II, First-in-Human Trial of TK216: A First-Generation EWS::FLI1 Fusion Protein Antagonist in Ewing Sarcoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Kay Nakazawa, Taryn Shaw, Young K Song, Marilyn Kouassi-Brou, Anna Molotkova, Purushottam B Tiwari, Hsien-Chao Chou, Xinyu Wen, Jun S Wei, Emre Deniz, Jeffrey A Toretsky, Charles Keller, Frederic G Barr, Javed Khan, Aykut Üren
Piperacetazine directly binds to the PAX3::FOXO1 fusion protein and inhibits its transcriptional activity. Cancer research communications (2023)
Matthew Zatzman, Fabio Fuligni, Ryan Ripsman, Tannu Suwal, Federico Comitani, Lisa-Monique Edward, Robert E Denroche, Gun Ho Jang, Faiyaz Notta, Steven Gallinger, Saravana P Selvanathan, Jeffrey A Toretsky, Matthew D Hellmann, Uri Tabori, Annie Huang, Adam Shlien
Widespread hypertranscription in aggressive human cancers. Science advances 8 (47) (2022)
Stefan K Zöllner, James F Amatruda, Sebastian Bauer, Stéphane Collaud, Enrique de Álava, Steven G DuBois, Jendrik Hardes, Wolfgang Hartmann, Heinrich Kovar, Markus Metzler, David S Shulman, Arne Streitbürger, Beate Timmermann, Jeffrey A Toretsky, Yasmin Uhlenbruch, Volker Vieth, Thomas G P Grünewald, Uta Dirksen
Ewing Sarcoma-Diagnosis, Treatment, Clinical Challenges and Future Perspectives. Journal of clinical medicine 10 (8) (2021)
Nathaniel D Anderson, Richard J de Borja, Matthew D Young, Fabio Fuligni, Andrej Rosic, Nicola D Roberts, Simon Hajjar, Mehdi Layeghifard, Ana Novokmet, Paul E Kowalski, Matthew Anaka, Scott Davidson, Mehdi Zarrei, Badr Id Said, L Christine Schreiner, Remi Marchand, Joseph Sitter, Nalan Gokgoz, Ledia Brunga, Garrett T Graham, Anthony Fullam, Nischalan Pillay, Jeffrey A Toretsky, Akihiko Yoshida, Tatsuhiro Shibata, Markus Metzler, Gino R Somers, Stephen W Scherer, Adrienne M Flanagan, Peter J Campbell, Joshua D Schiffman, Mary Shago, Ludmil B Alexandrov, Jay S Wunder, Irene L Andrulis, David Malkin, Sam Behjati, Adam Shlien
Rearrangement bursts generate canonical gene fusions in bone and soft tissue tumors. Science (New York, N.Y.) 361 (6405) (2018)
Stefan K Zöllner, Saravana P Selvanathan, Garrett T Graham, Ryan M T Commins, Sung Hyeok Hong, Eric Moseley, Sydney Parks, Jessica N Haladyna, Hayriye V Erkizan, Uta Dirksen, Michael D Hogarty, Aykut Üren, Jeffrey A Toretsky
Inhibition of the oncogenic fusion protein EWS-FLI1 causes G2-M cell cycle arrest and enhanced vincristine sensitivity in Ewing's sarcoma. Science signaling 10 (499) (2017)